Reports

- Global Locations -

Headquarters

Future Market Insights, Inc.

Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States

T: +1-347-918-3531

Americas

Future Market Insights, Inc.

616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States

MEA

Future Market Insights

1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates

Europe

Future Market Insights

3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom

T: + 44 (0) 20 8123 9659

Asia Pacific

Future Market Insights

IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India

Cell Dissociation Market Outlook 2023 to 2033

The cell dissociation market is projected to achieve a valuation of US$ 352.91 million by 2023, with a CAGR of 13.55% from 2023 to 2033. The cell dissociation business is projected to have a turnover of US$ 1,257.59 million by 2033.

Cell dissociation is an essential activity in biopharmaceutical research since it’s involved in medication development and disease explanation. As a result, higher research and development spending by biopharmaceutical companies is spearheading cell dissociation market expansion.

The sector is expanding to assist researchers and pharmaceutical companies in their efforts to study, and use cells. Since cell culture technology played a significant role in identifying therapeutic and innovative diagnostic alternatives, the pandemic increased demand.

The cell dissociation market is expanding due to the crucial tools that culturing techniques for vaccine development. The primary factor fueling the cell dissociation industry expansion is the increased emphasis on creating cell-based therapies. Market expansion is being fueled by an increase in clinical trials, FDA approvals, and strategic moves by leading companies.

  • Sanofi and Innate Pharma SA increased their cooperation with Sanofi for natural killer cell therapies in oncology in 2022.
  • Collaboration and license agreement to develop four iPSC-derived initiatives was announced by Century Therapeutics and Bristol Myers Squibb in September 2022.

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Key Influential Parameters

  • The predominance of cell-based research launched by pharmaceutical and biotechnology businesses fuels the cell dissociation industry expansion.
  • Numerous pharmaceutical and biotech companies are growing globally. This is another aspect pushing the cell dissociation market forward.
  • The biotechnology industry requires improved enzymes that aid in tissue dissociation. This cell dissociation demand propels the market forward.

Although, in several areas, ethical constraints and concerns about the use of cell-based research limit the progress of cell biology.

Market Outlook: 2018 to 2022 versus the Future 2023 to 2033

The cell dissociation market was worth US$ 200.25 million in 2018, with a CAGR of 12% from 2018 to 2022. By 2022, the cell dissociation business reached a revenue of US$ 315.10 million.

The market, on the other hand, is estimated to be worth US$ 352.91 million by 2023, with a CAGR of 13.55% through 2033. By 2033, the cell dissociation business is expected to have a revenue of US$ 1,257.59 million.

Shift Toward Enzymatic Dissociation: Conventionally, mechanical methods were commonly used to break down tissue and cells. In recent years, there has been a significant shift toward enzymatic methods, which are efficient and gentler on cells.

Development of New Dissociation Reagents: Over the years, researchers have developed new and improved dissociation reagents, including proteolytic enzymes and chelating agents. This has enabled the dissociation of a wider range of cell types and tissues with greater accuracy and efficiency.

Increased Demand for Animal-free and Xeno-free Dissociation Reagents: With the rise of regenerative medicine and cell-based therapies, there has been a growing demand for animal-free and xeno-free dissociation reagents. It helps to reduce the risk of contamination and improves cell viability.

Growth in Stem Cell Research: The use of cell dissociation methods has become increasingly important in the field of stem cell research. As dissociated cells are often used to generate induced pluripotent stem cells (iPSCs) and other cell types for research and therapeutic applications.

Advancements in Cell-based Therapies: The development of cell-based therapies, such as CAR-T cell therapy and stem cell transplantation, has driven dissociation reagents demand and enzymes for the isolation and therapeutic cell expansion.

Growing Research in Drug Discovery: The use of cell-based assays in drug discovery has led to increased demand for dissociation reagents and enzymes to isolate and culture cells for high-throughput screening.

Attributes Details
Cell Dissociation Market HCAGR (2018 to 2022) 12%
Cell Dissociation Market CAGR (2023 to 2033) 13.55%
Cell Dissociation Market Size (2022) US$ 315.10 million
Cell Dissociation Market Size (2023) US$ 352.91 million
Cell Dissociation Market Size (2033) US$ 1,257.59 million
Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Technological Breakthroughs in Cell Dissociation Products Foster Market Growth

The rising interest in personalized medicine and regenerative medicine is set to propel the demand for cell dissociation solutions. Cell dissociation is a critical stage that involves evaluating a patient's genetic profile to determine specific treatment options.

Cell dissociation materials are used to develop cell-based therapies and regenerative medicine solutions. As chronic and infectious diseases grow increasingly widespread, demand for cell dissociation products is likely to rise. Cell-based assays are used to diagnose and treat diseases such as cancer, Alzheimer's disease, and diabetes.

The technological advancements in cell dissociation products are propelling the market's revenue. With the development of reagents and kits that provide efficient cell dissociation, the usage in research and development applications may increase.

Efficient Usage of Automation in Cell Dissociation Pushes Market Forward

The increased application of automation in cell dissociation is positively influencing market revenue growth. By reducing human error, automating the cell dissociation processes boosts productivity.

Another element promoting the uptake of automated cell dissociation systems is the growing need for high-throughput screening in drug discovery and development. The utilization of products to rise as integrated systems that combine cell dissociation with subsequent processing procedures is evolved.

The increased requirement for research and development in biopharmaceutical firms is a key reason driving cell dissociation market expansion. The favorable financing landscape for cancer research and the rising incidence and prevalence of diseases stimulate market growth.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Roadblocks of the Market

The rising expense of cell-based research and the lack of infrastructure for cell-based research in developing nations may stymie market expansion. The intricacies of cell dissociation operations, as well as a scarcity of qualified personnel limit cell dissociation market revenue growth.

The growing emphasis on customized medicine and increased government support for cell-based research is expected to deflate market growth. Alternative cell dissociation procedures, such as sonication and freeze-thaw cycles, are expected to limit market revenue growth. Although, Small firms and new entrants may pose a threat to the growth of the cell dissociation industry.

Comparative View of Adjacent Cell Dissociation Market

Cell Dissociation Market:

Attributes Cell Dissociation Market
CAGR (2023 to 2033) 13.55%
Market Value (2023) US$ 352.91 million
Growth Factor The enzymatic cell dissociation market may expand profitably as more research projects use these kinds of enzymes often.
Opportunity Market participants are funding toxicity and efficacy research on cell dissociation enzymes. This element is responsible for the enormous market growth.
Key Trends Due to an increase in cell-based research and development activities, emerging markets may present considerable growth potential for players.

Cell Lysis & Disruption Market:

Attributes Cell Lysis & Disruption Market
CAGR (2023 to 2033) 9.35%
Market Value (2023) US$ 5.35 billion
Growth Factor The widespread use of biotechnology procedures combined with an increase in the use of gene expression methods.
Opportunity Prominent enterprises moved their attention to providing bioprocessing-related solutions, resulting in significant revenue growth.
Key Trends Increased research and development operations for vaccine development have increased the demand for bioprocessing technologies.

Cellular Immunotherapy Market:

Attributes Cellular Immunotherapy Market
CAGR (2023 to 2033) 22.41%
Market Value (2023) US$ 9.19 billion
Growth Factor The development of sophisticated cell-based therapies and the increased prevalence of cancer is supporting market expansion.
Opportunity The rise in product approvals and rising acceptance of cancer medicines positively influence the market expansion.
Key Trends Growing research and development investment by prominent firms is one of the contributing factors to market growth.

Segmentation Outlook

Which Products Have a Substantial Market Share?

Attribute Details
Enzymatic dissociation Segment Share 47.9%
Leading CAGR Segment Non-enzymatic Segment

In 2023, the enzymatic dissociation segment dominated the global industry and held a significant share. Enzymatic dissociation is a technique that uses enzymes to break down the cut-up tissue fragments, freeing the cells from the tissue. Many types of enzymes are utilized in the dissociation process, and they can also be used in tandem. All enzymatic dissociations are more successful and efficient in separating mononuclear cells from the spinal cord and brain. From 2023 to 2033, the non-enzymatic segment is expected to rise at a significant CAGR.

The enzyme-free formulation aids in the preservation of the functional and structural integrity of cell surface proteins. It also has the advantage of avoiding the cytotoxic effects of chelating drugs. The usage of animal-derived components is subjecting biopharmaceutical manufacturers to increased regulatory scrutiny.

Non-enzymatic products for cell culture are needed, which might accelerate category expansion. The solution is not recommended for cells with unique sticky qualities. The biopharmaceutical sector has created a Papain Dissociation Solution for difficult-to-remove cell lines.

Which Cell Dissociation Type is Going to Gain a Significant Market Revenue Share?

Attribute Details
Tissue Dissociation Type Segment Share 56.55%
Leading CAGR Segment Cell Detachment Type Segment

The industry has been divided into two types: tissue dissociation and cell detachment. The tissue dissociation type segment led the global industry in 2022, accounting for a huge proportion.

The segment may continue to increase at a steady rate, retaining its dominant position in the global market. Factors such as the increased focus of biopharmaceutical and pharmaceutical firms on the development of monoclonal antibodies and therapy customization may drive the expansion of this segment.

Cell detachment type segment, on the other hand, is expected to develop at a significant rate during the projection period. Cell detachment is essential in the culture of adherent cells. The most prevalent method of separation is trypsinization.

Increasing investment in cell culture product launches and strategic initiatives by leading industry players are among the fundamental factors driving this segment's growth.

Which End User Segment is Highly Prolific Globally?

Attribute Details
Pharmaceutical and Biotechnology Companies Segment Share 71.60%
Leading CAGR Segment Pharmaceutical and Biotechnology Companies Segment

The industry has been subdivided into pharmaceutical and biotechnology enterprises, as well as research and academic institutes, based on end-users. During the projection period, the category is projected to develop at a considerable CAGR while maintaining its prominent position in the global market.

This segment's significant portion and rapid growth can be due to the extensive usage of cell dissociation enzymes in pharmaceuticals. Collagenase and trypsin are key enzymes for preserving solid tissues and adherent cells for culturing and research. Cell tissue disaggregation and dissociation represent the beginning of a wide range of research applications, including cancer treatments, cell multiplication, and vaccine manufacture.

Regional Outlook

Why is North America Exhibiting High Cell Dissociation Demand?

Attribute Details
North America Market Share 37.20%

North America dominated the global industry in 2023, accounting for around 37.20% of total revenue. The region's huge proportion can be linked to the government's increased investment initiatives, the increasing frequency of chronic diseases such as cancer, and the presence of high-quality infrastructure for clinical and laboratory research in the region.

  • According to the Globocan study, about 2,281,658 new cancer cases were documented in the United States in 2020, with nearly 612,390 deaths.

The rising frequency of chronic and infectious diseases, combined with a greater emphasis on cell-based treatments, is broadening the market's potential prospects.

What is the Reason behind Asia Pacific's Rising Cell Dissociation Demand?

Due to increased demand for innovative treatments, the Asia Pacific region to develop at a swift rate throughout the forecast period. Rising government investments and rapid infrastructure development are significant drivers of booming market expansion. Some regional businesses are receiving financing to investigate treatments for chronic diseases such as cancer.

  • Immuneel Therapeutics, for example, won a US$ 15 million budget in June 2022 to develop cheap cell and gene therapy for cancer patients in India.

How Can Competitive Pressure Shape the Cell Dissociation Market?

To increase their market position, leading firms are using a variety of techniques, such as the introduction of novel products, partnerships, collaborations, mergers & acquisitions, and geographic growth.

  • S2 Genomics introduced the Singulator 100 System in February 2020. For a wide range of genomic analyses and single-cell biology, the system automates the processing of solid tissue samples into suspensions of nuclei or single cells with high yields and from tiny samples. The device standardizes the process for separating solid tissues, making it easy for researchers to consistently create suspensions of excellent, highly viable nuclei or cells with little variation.

Developments in the Cell Dissociation Approach

  • Acquisitions
Date December 8, 2021
Company Thermo Fisher Scientific Inc.
Details Thermo Fisher Scientific Inc. purchased PPD, Inc., a well-known supplier of clinical research services. The deal, which was estimated to be worth US$ 17.4 billion, was made to strengthen Thermo Fisher Scientific's position in the life sciences industry.
Date April 9, 2020
Company Bio-Rad Laboratories, Inc.
Details Bio-Rad Laboratories, Inc. purchased Celsee, Inc., a top producer of single-cell analysis tools. The goal of the acquisition was to increase the range of single-cell analytic products offered by Bio-Rad Laboratories.
Date June 1, 2020
Company Straub Medical AG
Details Straub Medical AG, a significant supplier of medical tools for the detection and treatment of venous diseases, was acquired by Becton, Dickinson and Company. The acquisition aimed to increase the range of products offered by the Company in the vascular access sector.

Key Players

  • HiMedia Laboratories
  • F. Hoffmann-La Roche Ltd.
  • Merck KGaA
  • Thermo Fisher Scientific
  • Sartorius AG
  • S2 Genomics, Inc.
  • Danaher Corp.
  • STEMCELL Technologies
  • BD
  • Miltenyi Biotec
  • PAN-Biotech

Key Segments

Cell Dissociation Industry by Product:

  • Enzymatic dissociation
  • Non-enzymatic dissociation
  • Instruments & Accessories

Cell Dissociation Industry by Type:

  • Cell dissociation for Tissue Dissociation
  • Cell dissociation for Cell Detachment

Cell Dissociation Industry by End User:

  • Cell dissociation for Pharmaceutical and Biotechnology Companies
  • Cell dissociation for Research and Academic Institutes

Cell Dissociation Industry by Region:

  • Cell dissociation in North America Market
  • Cell dissociation in Latin America Market
  • Cell dissociation in Europe Market
  • Cell dissociation in East Asia Market
  • Cell dissociation in South Asia and Pacific Market
  • Cell dissociation in The Middle East and Africa (MEA) Market

Frequently Asked Questions

How Big is the Cell Dissociation Market?

The market is valued at US$ 352.91 million in 2023.

What is the Growth Potential of the Cell Dissociation Market?

The overall market is projected to surge at a 13.55% annual growth rate through 2033.

What is the Predicted Size of the Cell Dissociation Market in Ten Years?

The market is estimated to be worth US$ 1,257.59 million by 2033.

How Big is the Enzymatic Dissociation Market Segment?

This segment held 47.9% of the global market share in 2022.

Which is the Prominent Cell Dissociation Type Market Segment?

The tissue dissociation segment accounted for 56.55% of the total market share in 2022.

Table of Content

1. Executive Summary | Cell Dissociation Market

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Investment Feasibility Matrix

    3.5. PESTLE and Porter’s Analysis

    3.6. Regulatory Landscape

        3.6.1. By Key Regions

        3.6.2. By Key Countries

    3.7. Regional Parent Market Outlook

4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033

    4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022

    4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Million) Analysis By Product, 2018 to 2022

    5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Product, 2023 to 2033

        5.3.1. Enzymatic Dissociation

        5.3.2. Non-enzymatic dissociation

    5.4. Y-o-Y Growth Trend Analysis By Product, 2018 to 2022

    5.5. Absolute $ Opportunity Analysis By Product, 2023 to 2033

6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Type

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Million) Analysis By Type, 2018 to 2022

    6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Type, 2023 to 2033

        6.3.1. Tissue Dissociation

        6.3.2. Cell Detachment

    6.4. Y-o-Y Growth Trend Analysis By Type, 2018 to 2022

    6.5. Absolute $ Opportunity Analysis By Type, 2023 to 2033

7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End-use

    7.1. Introduction / Key Findings

    7.2. Historical Market Size Value (US$ Million) Analysis By End-use, 2018 to 2022

    7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End-use, 2023 to 2033

        7.3.1. Pharmaceutical and Biotechnology Companies

        7.3.2. Research & Academic Institutes

    7.4. Y-o-Y Growth Trend Analysis By End-use, 2018 to 2022

    7.5. Absolute $ Opportunity Analysis By End-use, 2023 to 2033

8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region

    8.1. Introduction

    8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022

    8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033

        8.3.1. North America

        8.3.2. Latin America

        8.3.3. Europe

        8.3.4. South Asia

        8.3.5. East Asia

        8.3.6. Oceania

        8.3.7. MEA

    8.4. Market Attractiveness Analysis By Region

9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        9.2.1. By Country

            9.2.1.1. USA

            9.2.1.2. Canada

        9.2.2. By Product

        9.2.3. By Type

        9.2.4. By End-use

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Product

        9.3.3. By Type

        9.3.4. By End-use

    9.4. Key Takeaways

10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        10.2.1. By Country

            10.2.1.1. Brazil

            10.2.1.2. Mexico

            10.2.1.3. Rest of Latin America

        10.2.2. By Product

        10.2.3. By Type

        10.2.4. By End-use

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Product

        10.3.3. By Type

        10.3.4. By End-use

    10.4. Key Takeaways

11. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        11.2.1. By Country

            11.2.1.1. Germany

            11.2.1.2. United kingdom

            11.2.1.3. France

            11.2.1.4. Spain

            11.2.1.5. Italy

            11.2.1.6. Rest of Europe

        11.2.2. By Product

        11.2.3. By Type

        11.2.4. By End-use

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Product

        11.3.3. By Type

        11.3.4. By End-use

    11.4. Key Takeaways

12. South Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        12.2.1. By Country

            12.2.1.1. India

            12.2.1.2. Malaysia

            12.2.1.3. Singapore

            12.2.1.4. Thailand

            12.2.1.5. Rest of South Asia

        12.2.2. By Product

        12.2.3. By Type

        12.2.4. By End-use

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Product

        12.3.3. By Type

        12.3.4. By End-use

    12.4. Key Takeaways

13. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        13.2.1. By Country

            13.2.1.1. China

            13.2.1.2. Japan

            13.2.1.3. South Korea

        13.2.2. By Product

        13.2.3. By Type

        13.2.4. By End-use

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Product

        13.3.3. By Type

        13.3.4. By End-use

    13.4. Key Takeaways

14. Oceania Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        14.2.1. By Country

            14.2.1.1. Australia

            14.2.1.2. New Zealand

        14.2.2. By Product

        14.2.3. By Type

        14.2.4. By End-use

    14.3. Market Attractiveness Analysis

        14.3.1. By Country

        14.3.2. By Product

        14.3.3. By Type

        14.3.4. By End-use

    14.4. Key Takeaways

15. MEA Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        15.2.1. By Country

            15.2.1.1. GCC Countries

            15.2.1.2. South Africa

            15.2.1.3. Israel

            15.2.1.4. Rest of MEA

        15.2.2. By Product

        15.2.3. By Type

        15.2.4. By End-use

    15.3. Market Attractiveness Analysis

        15.3.1. By Country

        15.3.2. By Product

        15.3.3. By Type

        15.3.4. By End-use

    15.4. Key Takeaways

16. Key Countries Market Analysis

    16.1. USA

        16.1.1. Pricing Analysis

        16.1.2. Market Share Analysis, 2022

            16.1.2.1. By Product

            16.1.2.2. By Type

            16.1.2.3. By End-use

    16.2. Canada

        16.2.1. Pricing Analysis

        16.2.2. Market Share Analysis, 2022

            16.2.2.1. By Product

            16.2.2.2. By Type

            16.2.2.3. By End-use

    16.3. Brazil

        16.3.1. Pricing Analysis

        16.3.2. Market Share Analysis, 2022

            16.3.2.1. By Product

            16.3.2.2. By Type

            16.3.2.3. By End-use

    16.4. Mexico

        16.4.1. Pricing Analysis

        16.4.2. Market Share Analysis, 2022

            16.4.2.1. By Product

            16.4.2.2. By Type

            16.4.2.3. By End-use

    16.5. Germany

        16.5.1. Pricing Analysis

        16.5.2. Market Share Analysis, 2022

            16.5.2.1. By Product

            16.5.2.2. By Type

            16.5.2.3. By End-use

    16.6. United kingdom

        16.6.1. Pricing Analysis

        16.6.2. Market Share Analysis, 2022

            16.6.2.1. By Product

            16.6.2.2. By Type

            16.6.2.3. By End-use

    16.7. France

        16.7.1. Pricing Analysis

        16.7.2. Market Share Analysis, 2022

            16.7.2.1. By Product

            16.7.2.2. By Type

            16.7.2.3. By End-use

    16.8. Spain

        16.8.1. Pricing Analysis

        16.8.2. Market Share Analysis, 2022

            16.8.2.1. By Product

            16.8.2.2. By Type

            16.8.2.3. By End-use

    16.9. Italy

        16.9.1. Pricing Analysis

        16.9.2. Market Share Analysis, 2022

            16.9.2.1. By Product

            16.9.2.2. By Type

            16.9.2.3. By End-use

    16.10. India

        16.10.1. Pricing Analysis

        16.10.2. Market Share Analysis, 2022

            16.10.2.1. By Product

            16.10.2.2. By Type

            16.10.2.3. By End-use

    16.11. Malaysia

        16.11.1. Pricing Analysis

        16.11.2. Market Share Analysis, 2022

            16.11.2.1. By Product

            16.11.2.2. By Type

            16.11.2.3. By End-use

    16.12. Singapore

        16.12.1. Pricing Analysis

        16.12.2. Market Share Analysis, 2022

            16.12.2.1. By Product

            16.12.2.2. By Type

            16.12.2.3. By End-use

    16.13. Thailand

        16.13.1. Pricing Analysis

        16.13.2. Market Share Analysis, 2022

            16.13.2.1. By Product

            16.13.2.2. By Type

            16.13.2.3. By End-use

    16.14. China

        16.14.1. Pricing Analysis

        16.14.2. Market Share Analysis, 2022

            16.14.2.1. By Product

            16.14.2.2. By Type

            16.14.2.3. By End-use

    16.15. Japan

        16.15.1. Pricing Analysis

        16.15.2. Market Share Analysis, 2022

            16.15.2.1. By Product

            16.15.2.2. By Type

            16.15.2.3. By End-use

    16.16. South Korea

        16.16.1. Pricing Analysis

        16.16.2. Market Share Analysis, 2022

            16.16.2.1. By Product

            16.16.2.2. By Type

            16.16.2.3. By End-use

    16.17. Australia

        16.17.1. Pricing Analysis

        16.17.2. Market Share Analysis, 2022

            16.17.2.1. By Product

            16.17.2.2. By Type

            16.17.2.3. By End-use

    16.18. New Zealand

        16.18.1. Pricing Analysis

        16.18.2. Market Share Analysis, 2022

            16.18.2.1. By Product

            16.18.2.2. By Type

            16.18.2.3. By End-use

    16.19. GCC Countries

        16.19.1. Pricing Analysis

        16.19.2. Market Share Analysis, 2022

            16.19.2.1. By Product

            16.19.2.2. By Type

            16.19.2.3. By End-use

    16.20. South Africa

        16.20.1. Pricing Analysis

        16.20.2. Market Share Analysis, 2022

            16.20.2.1. By Product

            16.20.2.2. By Type

            16.20.2.3. By End-use

    16.21. Israel

        16.21.1. Pricing Analysis

        16.21.2. Market Share Analysis, 2022

            16.21.2.1. By Product

            16.21.2.2. By Type

            16.21.2.3. By End-use

17. Market Structure Analysis

    17.1. Competition Dashboard

    17.2. Competition Benchmarking

    17.3. Market Share Analysis of Top Players

        17.3.1. By Regional

        17.3.2. By Product

        17.3.3. By Type

        17.3.4. By End-use

18. Competition Analysis

    18.1. Competition Deep Dive

        18.1.1. Merck KGaA

            18.1.1.1. Overview

            18.1.1.2. Product Portfolio

            18.1.1.3. Profitability by Market Segments

            18.1.1.4. Sales Footprint

            18.1.1.5. Strategy Overview

                18.1.1.5.1. Marketing Strategy

        18.1.2. Thermo Fisher Scientific

            18.1.2.1. Overview

            18.1.2.2. Product Portfolio

            18.1.2.3. Profitability by Market Segments

            18.1.2.4. Sales Footprint

            18.1.2.5. Strategy Overview

                18.1.2.5.1. Marketing Strategy

        18.1.3. Danaher Corp.

            18.1.3.1. Overview

            18.1.3.2. Product Portfolio

            18.1.3.3. Profitability by Market Segments

            18.1.3.4. Sales Footprint

            18.1.3.5. Strategy Overview

                18.1.3.5.1. Marketing Strategy

        18.1.4. STEMCELL Technologies

            18.1.4.1. Overview

            18.1.4.2. Product Portfolio

            18.1.4.3. Profitability by Market Segments

            18.1.4.4. Sales Footprint

            18.1.4.5. Strategy Overview

                18.1.4.5.1. Marketing Strategy

        18.1.5. Sartorius AG

            18.1.5.1. Overview

            18.1.5.2. Product Portfolio

            18.1.5.3. Profitability by Market Segments

            18.1.5.4. Sales Footprint

            18.1.5.5. Strategy Overview

                18.1.5.5.1. Marketing Strategy

        18.1.6. Miltenyi Biotech

            18.1.6.1. Overview

            18.1.6.2. Product Portfolio

            18.1.6.3. Profitability by Market Segments

            18.1.6.4. Sales Footprint

            18.1.6.5. Strategy Overview

                18.1.6.5.1. Marketing Strategy

        18.1.7. PAN-Biotech

            18.1.7.1. Overview

            18.1.7.2. Product Portfolio

            18.1.7.3. Profitability by Market Segments

            18.1.7.4. Sales Footprint

            18.1.7.5. Strategy Overview

                18.1.7.5.1. Marketing Strategy

        18.1.8. HiMedia Laboratories

            18.1.8.1. Overview

            18.1.8.2. Product Portfolio

            18.1.8.3. Profitability by Market Segments

            18.1.8.4. Sales Footprint

            18.1.8.5. Strategy Overview

                18.1.8.5.1. Marketing Strategy

        18.1.9. F. Hoffmann-La Roche Ltd.

            18.1.9.1. Overview

            18.1.9.2. Product Portfolio

            18.1.9.3. Profitability by Market Segments

            18.1.9.4. Sales Footprint

            18.1.9.5. Strategy Overview

                18.1.9.5.1. Marketing Strategy

        18.1.10. S2 Genomics, Inc.

            18.1.10.1. Overview

            18.1.10.2. Product Portfolio

            18.1.10.3. Profitability by Market Segments

            18.1.10.4. Sales Footprint

            18.1.10.5. Strategy Overview

                18.1.10.5.1. Marketing Strategy

19. Assumptions & Acronyms Used

20. Research Methodology

Recommendations

Healthcare

Stem Cell Therapy Market

Published : March 2024

Healthcare

Small Cell Lung Cancer (SCLC) Treatment Market

Published : December 2022

Explore Healthcare Insights

View Reports